
On December 21, 2024, the federal government slipped a major policy change into a spending bill that caught many in the hemp industry off guard. Buried within the appropriations legislation, Section 759 fundamentally altered how hemp is defined under federal law—potentially rendering thousands of products illegal overnight.
During a recent Qredible Live broadcast, Doug Fischer, General Counsel at Active and President of Vape Safer, provided crucial insights into what Section 759 actually changes and how the industry can respond. Fischer, who has worked in cannabis law since 2017 and previously served as General Counsel for multiple cannabis companies, including publicly-traded Green Lane Holdings and MSO Ascend Wellness Holdings, explained the immediate implications and long-term strategies for businesses facing this regulatory upheaval.
To understand the impact of Section 759, you need to know what the 2018 Farm Bill originally established. As Fischer explained, marijuana has always been defined under federal law as "the cannabis sativa L plant having more than 0.3% delta 9 THC by dry weight." The 2018 Farm Bill removed hemp—defined as cannabis with less than 0.3% delta-9 THC—from the controlled substances schedule, making it federally legal.
"The 2018 Farm Bill came along and removed from the definition of marijuana the hemp plant, right? and its extracts and derivatives," Fischer noted. This created a legal pathway that, while originally intended for industrial hemp applications like textiles and animal feed, also enabled the creation of intoxicating cannabinoid products.
Section 759 closes that pathway through three key changes:
The new law counts all forms of THC, not just delta-9. "Previously it was hey you could have a plant with less than 0.3% delta 9 THC but it had THCA which is a precursor to delta 9 THC if it's heated," Fischer explained. "We're now counting the 0.3 all THC."
Any isolates, distillates, or extracts containing more than 0.3% of any type of THC or any synthetic cannabinoids are now prohibited. This affects the raw materials companies use to manufacture finished products.
The most restrictive change applies to consumer products: "If it has more than 0.4 milligrams of THC again any type of THC per container then that is also not allowed," Fischer stated. These three provisions combined eliminate nearly every hemp-derived intoxicating product currently on the market.
Section 759 includes a 365-day grace period before enforcement begins, giving the industry time to adapt. However, Fischer cautioned that this window is shorter than it appears, especially with 2026 midterm elections consuming Congressional attention.
During this period, businesses face several immediate concerns:
Tax Implications: Hemp businesses that continue operating with products now classified as Schedule I controlled substances become subject to 280E tax restrictions, which prohibit standard business deductions for companies trafficking in controlled substances.
Compliance Obligations: Even during the grace period, companies must prepare for the new reality. "The days of compliance theater, it's over," Fischer emphasized. "Mere performative compliance or box-checking is now the peril and the downfall."
Legal Exposure: The recent RICO case (Medical Marijuana v. Horn) established that civil RICO claims can proceed for mislabeled CBD products, adding another layer of legal risk for companies with inaccurate labeling or testing.
While Section 759 appeared suddenly in a spending bill, Fischer noted the regulatory pressure had been building. "Just a few weeks ago 39 states attorneys generals wrote a letter to Congress saying, 'I'm seeing this Delta 8 and this HHC in gas stations. Please stop it,'" he explained.
The unregulated hemp market created tension between state-licensed cannabis operators who faced strict regulations and hemp businesses operating with minimal oversight. "You've got an overregulated state marijuana industry that's saying this isn't fair at all. And you've got a potentially underregulated hemp industry saying, 'Hey, we're going to do what we want to do,'" Fischer observed.
Bad actors didn't help. Products designed to appeal to minors, synthetic cannabinoids in gas stations, and inaccurate labeling gave opponents powerful ammunition. "You see, you know, they tried to ban it in Texas and you've got the governor standing up there or the lieutenant governor standing up there showing these products," Fischer said.
Despite the severity of Section 759 hemp regulations, Fischer sees reasons for optimism. "The number of phone calls I've received in the past two days, three days of can we form this coalition, can we form that coalition? I'm looking online and all of a sudden all sorts of different groups are popping up," he reported shortly after the bill's passage.
Congress may revisit these restrictions during the upcoming Farm Bill renewal. Several prominent politicians from both parties have supported modified hemp legislation, including:
Fischer advocates for a fundamental shift in how hemp is regulated. "Let's regulate the cannabinoids not a plant. There's no reason for cannabis sativa L to be on the controlled substances schedule. What should be on the controlled substances schedule is whatever cannabinoids are appropriate to be there."
This approach would solve practical problems like the Kentucky hemp farmer Fischer described who faced crop losses during an unusually hot year. "THC spikes in heat and you know the farmers did everything they could do to control it. And that year the Kentucky Department of Agriculture didn't even test at harvest because they knew the whole state would be on fire," he recalled.
Interestingly, Section 759 itself hints at this approach by allowing up to 0.4 milligrams of THC per container—"the first time that I'm aware of that a federal piece of legislation has really one legislated by cannabinoid not by the plant that it comes from," Fischer noted.
States will need to reopen their hemp legislation to comply with the new federal definition, creating opportunities to establish sensible standards that could inform federal policy. "There's a ton of work to be done at the state level, too. And I don't I think that's equally important and might be even a better starting place for a lot of people," Fischer advised.
Fischer believes the current situation, while painful, creates incentive for previously antagonistic groups to work together. "Right now, it's all marijuana, right? It's all back to the status quo. All of it is a schedule one controlled substance. And so there's a real incentive for everyone to kind of set aside their narrower interests."
The key is focusing on regulatory pillars that protect public health without eliminating the industry:
"Good actors are defined by the standards they uphold, not which plant they get their cannabinoids from," Fischer argued. "Whatever feelings you may have about the past, like we'll all benefit if that's the mindset."
The Section 759 hemp regulations represent a critical inflection point. Companies that treat compliance as theater rather than genuine commitment will face enforcement actions, civil liability, and exclusion from advocacy efforts. "If you want to walk into your representatives office or your senator's office or your state legislation, state legislator's office, but there's something in your Google history that says, 'Oh, their COAs were inaccurate or their labeling was inaccurate.' Guess what? You don't have a seat at the table, nor do you deserve one," Fischer stated bluntly.
However, businesses that embrace rigorous standards, engage in coalition-building, and advocate for science-based policy can shape a more sustainable future for hemp and cannabis. The 365-day grace period is not a countdown to closure—it's a window for transformation. As Fischer concluded, "This is a new homegrown industry that is less dependent upon foreign influences than the vast majority of industries in this country," making it worth fighting for with intelligence, integrity, and unity.